Media Inquiries: For all MAVA media inquiries, please contact Audrey Chang at 202-295-8779 or email audrey.chang@harbourgrp.com.
Check back regularly for news, coverage, and announcements about MAVA.
Verax Biomedical Inc., which has developed technology to enable rapid blood tests, has raised $2.78 million, or over 55 percent of a mixed offering of $5 million, from 11 investors, according to an SEC filing.
Principals named in the filing by the Worcester, Mass.-based firm are the following executives: Read More